The VC-backed microrobotics startup Bionaut Labs has entered into a strategic collaboration with Candel Therapeutics. Candel (NSDQ:CADL) — a biopharma focused on oncolytic viral immunotherapies — will explore the use of Bionaut Labs’ miniature remote-controlled robots. Could the robots help deliver Candel’s oncolytic viral immunotherapy agents to certain brain tumors? Founded in 2016, Bionaut Labs…